Astrazeneca

Latest Stories

Drug companies work jointly to boost vaccine confidence

By DANICA KIRKA and MARIA CHENG - Associated Press

A woman walks past a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange Monday, Sept. 14, 2020. Asian shares are rising, despite the rollercoast ride that closed Wall Street last week, as traders awaited cues from the U.S. central bank expected later in the week. (AP Photo/Vincent Yu)

Asian markets mixed after Wall Street rises on dealmaking

By JOE McDONALD - Associated Press

Oxford and AstraZeneca resume coronavirus vaccine trial

By PAN PYLAS - Associated Press

Vaccine trial stopped after neurological symptoms detected

By MARIA CHENG - Associated Press

HealthPartners suspends recruiting in COVID-19 vaccine trial

Associated Press

FILE - This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. (AP Photo/Alastair Grant, File)

Vaccine by Nov. 3? Halted study explains just how unlikely

By LAURAN NEERGAARD - Associated Press

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, speaks during a House Subcommittee on the Coronavirus crisis hearing, Friday, July 31, 2020, on Capitol Hill in Washington. (Kevin Dietsch/Pool via AP) ** FILE **

Dr. Anthony Fauci: ‘Unfortunate’ AstraZeneca had to pause vaccine trial

By David Sherfinski - The Washington Times

FILE - This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. (AP Photo/Alastair Grant, File)

AstraZeneca COVID-19 vaccine study paused after one illness

By LAURAN NEERGAARD - Associated Press

AstraZeneca has put a hold on its coronavirus vaccine trials as it investigates a patient who had a

Associated Press

A man wearing a face mask walks near a banner displaying as a part of campaign to overcome the coronavirus in Seoul, South Korea, Friday, Sept. 4, 2020. (AP Photo/Lee Jin-man)

Asia Today: India surges to world’s 2nd-worst virus caseload

Associated Press

A health worker takes a nasal swab sample to test for COVID-19 in New Delhi, India, Saturday, Sept. 5, 2020. India's coronavirus cases have crossed 4 million, leading the world in new infections and deepening misery in the country's vast hinterlands where surges have crippled the underfunded health care system. Initially, the virus ravaged India's sprawling and densely populated cities. It has since stretched to almost every state, spreading through villages. (AP Photo/Manish Swarup)

The Latest: Australia OKs funding for two potential vaccines

By The Associated Press - Associated Press

IU School of Medicine to test experimental COVID-19 vaccine

Associated Press

In this Aug. 14, 2020, file photo, laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. (AP Photo/Natacha Pisarenko, File)

Third virus vaccine reaches major hurdle: final US testing

By LAURAN NEERGAARD and CARLA K. JOHNSON - Associated Press

People wearing face masks pass by posters about precautions against the coronavirus at a subway station in Seoul, South Korea, Tuesday, Aug. 18, 2020. (AP Photo/Ahn Young-joon)

The Latest: Australia announces coronavirus vaccine deal

By The Associated Press - Associated Press

In this Thursday, Oct. 10, 2019, file photo, philanthropist and co-chairman of the Bill & Melinda Gates Foundation Bill Gates gestures as he speaks to the audience during the Global Fund to Fight AIDS event at the Lyon's congress hall, central France. (Ludovic Marin/Pool Photo via AP) ** FILE **

Gates Foundation, India maker partner on 100M doses of vaccine

By Tom Howell Jr. - The Washington Times

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The pandemic increased sales of Merck medicines during the first quarter of 2020, as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the outbreak lands. (AP Photo/Seth Wenig, File)

Merck ups outlook, turns profit during global vaccine hunt

By LINDA A. JOHNSON - Associated Press

AstraZeneca: won’t profit from COVID-19 vaccine in pandemic

By DANICA KIRKA - Associated Press

In this handout photo released by the University of Oxford a doctor takes blood samples for use in a coronavirus vaccine trial in Oxford, England, Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. (John Cairns, University of Oxford via AP)

UK coronavirus vaccine prompts immune response in early test

By MARIA CHENG - Associated Press

In this handout photo released by the University of Oxford, a doctor takes blood samples for use in a coronavirus vaccine trial in Oxford, England on Thursday, June 25, 2020. (John Cairns, University of Oxford via AP) ** FILE **

AstraZeneca-Oxford vaccine shows ‘robust’ immune response to the coronavirus

By Tom Howell Jr. - The Washington Times

Who would be the first to get a COVID-19 vaccine?

Associated Press